Spots Global Cancer Trial Database for capecitabine [xeloda]
Every month we try and update this database with for capecitabine [xeloda] cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048126 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | NCT00929240 | Breast Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours | NCT01493336 | Breast Cancer, ... | capecitabine RT... capecitabine [X... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00642603 | Colorectal Canc... | capecitabine [X... capecitabine [X... bevacizumab [Av... oxaliplatin irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | NCT00811135 | Breast Cancer | bevacizumab [Av... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. | NCT00502671 | Colorectal Canc... | capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048126 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours | NCT01493336 | Breast Cancer, ... | capecitabine RT... capecitabine [X... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. | NCT00439426 | Nasopharyngeal ... | Oxaliplatin capecitabine [X... | 18 Years - 75 Years | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | NCT00009737 | Colorectal Canc... | 5-Fluorouracil Leucovorin Capecitabine [X... | 18 Years - 75 Years | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048139 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. | NCT00502671 | Colorectal Canc... | capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer | NCT00845910 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel | 18 Years - 65 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | NCT00069108 | Colorectal Canc... | 5 FU Leucovorin Oxaliplatin Oxaliplatin capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer | NCT02013830 | Liver Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression | NCT01077726 | Breast Cancer | capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression | NCT01077726 | Breast Cancer | capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00642603 | Colorectal Canc... | capecitabine [X... capecitabine [X... bevacizumab [Av... oxaliplatin irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | NCT00811135 | Breast Cancer | bevacizumab [Av... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048139 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | NCT02005549 | Breast Cancer | bevacizumab [Av... docetaxel capecitabine [X... | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | NCT00929240 | Breast Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer | NCT00885755 | Breast Cancer | Standard taxane... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | NCT02005549 | Breast Cancer | bevacizumab [Av... docetaxel capecitabine [X... | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | NCT00089479 | Breast Cancer | capecitabine [X... Taxotere Taxotere | 18 Years - 70 Years | Hoffmann-La Roche | |
| ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | NCT00925769 | Pancreatic Canc... | bevacizumab [Av... capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048139 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | NCT00089479 | Breast Cancer | capecitabine [X... Taxotere Taxotere | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | NCT00811993 | Neoplasms | RG1507 RO1507 bevacizumab [Av... capecitabine [X... carboplatin cetuximab docetaxel erlotinib [Tarc... etoposide gemcitabine irinotecan mFOLFOX6 paclitaxel pemetrexel sorafenib temozolomide trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. | NCT00353262 | Colorectal Canc... | Avastin Oxaliplatin capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. | NCT01290718 | Breast Cancer | capecitabine [X... trastuzumab [He... | 18 Years - 65 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | NCT01159171 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | NCT01130337 | Gastric Cancer | Capecitabine [X... Oxaliplatin Trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer | NCT00885755 | Breast Cancer | Standard taxane... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer | NCT00700570 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | - 75 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer | NCT00700570 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | - 75 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | NCT01227707 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... Radiation thera... Mesorectal exci... bevacizumab [Av... 5-fluorouracil leucovorin | 18 Years - | Hoffmann-La Roche | |
| A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | NCT01130337 | Gastric Cancer | Capecitabine [X... Oxaliplatin Trastuzumab [He... | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
